<DOC>
	<DOCNO>NCT02446353</DOCNO>
	<brief_summary>A Randomized , Open Label , Single dose , Cross-over , Phase I Trial Investigate Safety Pharmacokinetics Apetrol ES Megace® Healthy Male Volunteers .</brief_summary>
	<brief_title>Pharmacokinetics Safety Study Apetrol ES</brief_title>
	<detailed_description>[ Part 1 ] fast [ Part 2 ] fed</detailed_description>
	<mesh_term>Megestrol Acetate</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<criteria>Is healty male 20 55 year old . In ± 20 % ideal body weight . [ ideal body weight ( kg ) = height ( cm ) 100 ) x 0.9 ( Broca 's rule ) Subjects consider suitable conduct clinical trial serum test , hematology test , hematochemical test , urine test 12ECG result . Is willing able comply schedule visit , treatment plan , laboratory test , study procedure . Agrees use adequate mean contraception clinical trial Subject voluntarily decide participate clinical trial consent writing . Is allergic Megestrol acetate drug ( Aspirin , NSAIDs , Antibiotics , etc . ) food , clinically serious allergic history . Subjects present condition past history disease involve liver , kidney , nervous system , immune system , respiratory system , endocrine system ; hematologic oncologic disease ; cardiovascular disease ; psychiatric disorder ( mood disorder , obsessivecompulsive disorder , etc . may affect ADME investigational medicinal product . In vital sign measure sit position screen visit , subject hypertension desease ( systolic blood pressure ≥ 150 mmHg diastolic blood pressure ≥ 100 mmHg ) . Diabetic patient patient abnormal impaired glucose tolerance . The patient history Arterial Embolism . The patient history adrenal insufficiency like hypotension nausea vertigo asthenia etc . Subjects history drug abuse show positive reaction drug may abuse urine drug screen Subjects take specialized drug herbal medication within 2 week date first administration take counter ( OTC ) drug within 1 week ( however , may include subject appropriate depend investigator 's discretion ) Subjects whole blood donation within 2 month component blood donation within 1 month clinical trial . Subjects abnormal diet may affect ADME investigational medicinal product . Subjects drink extremely alcohol caffeine ( caffeine 5 cups/day , soju 3 cups/day , beer 3 cups/day , liquor 2 cups/day , 10 cigarettes/day ) ca n't refrain drink clinical trial period . Subjects administration barbiturate within 1 month date first drug administration Subjects already participate clinical trial within 2 month clinical trial . Subjects consider unsuitable conduct clinical trial reason principal investigator 's discretionary judgment</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Male Volunteers</keyword>
</DOC>